报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2025-03-31 | 51% | -1.05% | -3.67% | 67/131 | 51.25% | 艾德生物 | 84% | 行业排名> |
2024-12-31 | 52.94% | 7.74% | 0.04% | 68/131 | 52.33% | 佰仁医疗 | 85.72% | 行业排名> |
2024-09-30 | 52.92% | 33.69% | 0.46% | 69/131 | 53.43% | 佰仁医疗 | 88.34% | 行业排名> |
2024-06-30 | 52.68% | 8.11% | 2.21% | 70/131 | 53.5% | 佰仁医疗 | 88.56% | 行业排名> |
2024-03-31 | 51.54% | 2% | 4.89% | 68/131 | 53.43% | 佰仁医疗 | 89.27% | 行业排名> |
2023-12-31 | 49.14% | 8.23% | 0.84% | 77/131 | 53.31% | 佰仁医疗 | 89.28% | 行业排名> |
2023-06-30 | 48.72% | 11.61% | 7.32% | 75/131 | 53.45% | 正海生物 | 89.9% | 行业排名> |
2022-12-31 | 45.4% | 19.05% | 4% | 83/131 | 53.83% | 正海生物 | 90.39% | 行业排名> |
2022-06-30 | 43.66% | 2% | 14.47% | 84/131 | 54.78% | 正海生物 | 90.3% | 行业排名> |
2021-12-31 | 38.14% | -10.98% | -3.65% | 106/131 | 57.29% | 正海生物 | 89.78% | 行业排名> |
2021-09-30 | 39.58% | 2% | -7.6% | 88/131 | 59.17% | 三友医疗 | 90.18% | 行业排名> |
2020-12-31 | 42.84% | 2% | 2% | 103/131 | 59.59% | 三友医疗 | 90.14% | 行业排名> |